Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-018903
Filing Date
2021-08-06
Accepted
2021-08-06 17:00:59
Documents
1
Period of Report
2021-08-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3891
  Complete submission text file 0001493152-21-018903.txt   5331
Mailing Address 550 HILLS DRIVE 3RD FLOOR BEDMINSTER NJ 07921
Business Address
O'CALLAGHAN BRIAN (Reporting) CIK: 0001415015 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40652 | Film No.: 211153649

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Issuer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations